达比加群与载脂蛋白B - Suppr

Suppr

超能文献

Dabigatran and apolipoprotein B.

作者信息

ten Cate Hugo

出版信息

Heart. 2016 Jan;102(1):5-6. doi: 10.1136/heartjnl-2015-308575. Epub 2015 Nov 13.

DOI:10.1136/heartjnl-2015-308575

PMID:26567229

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4717405/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e81d/4717405/21575649e7bc/heartjnl-2015-308575f01.jpg

相似文献

Dabigatran and apolipoprotein B.达比加群与载脂蛋白B

Heart. 2016 Jan;102(1):5-6. doi: 10.1136/heartjnl-2015-308575. Epub 2015 Nov 13.

Dabigatran etexilate and reduction in serum apolipoprotein B.达比加群酯与血清载脂蛋白B降低

Heart. 2016 Jan;102(1):57-62. doi: 10.1136/heartjnl-2015-307586. Epub 2015 Nov 9.

Sex-Specific Comparative Effectiveness of Oral Anticoagulants in Elderly Patients With Newly Diagnosed Atrial Fibrillation.口服抗凝剂在新诊断房颤老年患者中的性别特异性比较疗效

Circ Cardiovasc Qual Outcomes. 2017 Apr;10(4). doi: 10.1161/CIRCOUTCOMES.116.003418.

Meta-analysis of dabigatran vs warfarin in patients undergoing catheter ablation for atrial fibrillation.达比加群与华法林用于心房颤动导管消融患者的荟萃分析。

Int J Cardiol. 2015 Jun 15;189:199-203. doi: 10.1016/j.ijcard.2015.04.072. Epub 2015 Apr 11.

[Comparison of the cost-utility of direct oral anticoagulants for the prevention of stroke in patients with atrial fibrillation in Spain].[西班牙直接口服抗凝剂预防心房颤动患者中风的成本效益比较]

Rev Neurol. 2017 Mar 16;64(6):247-256.

Management of dental patients taking direct oral anticoagulants: Dabigatran.直接口服抗凝剂治疗患者的口腔管理：达比加群。

Oral Dis. 2018 Mar;24(1-2):228-232. doi: 10.1111/odi.12755.

Systematic review of cost-effectiveness analyses of novel oral anticoagulants for stroke prevention in atrial fibrillation.新型口服抗凝剂用于心房颤动患者卒中预防的成本效益分析的系统评价

Rev Port Cardiol. 2015 Mar;34(3):179-91. doi: 10.1016/j.repc.2014.08.008. Epub 2015 Feb 27.

Does dabigatran interfere with intraablation heparinization?

Thromb Res. 2014 Sep;134(3):742-3. doi: 10.1016/j.thromres.2014.06.026. Epub 2014 Jul 5.

Is one month treatment with dabigatran before cardioversion of atrial fibrillation sufficient to prevent thromboembolism?在心房颤动转复之前使用达比加群酯治疗一个月是否足以预防血栓栓塞？

Europace. 2015 Oct;17(10):1514-7. doi: 10.1093/europace/euv123. Epub 2015 May 27.

A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants.一项全国性注册研究，旨在比较服用口服抗凝剂的心房颤动患者的出血率。

Eur Heart J Cardiovasc Pharmacother. 2017 Jan;3(1):28-36. doi: 10.1093/ehjcvp/pvw031. Epub 2016 Sep 27.

引用本文的文献

Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target.载脂蛋白B与心血管疾病：生物标志物及潜在治疗靶点

Metabolites. 2021 Oct 8;11(10):690. doi: 10.3390/metabo11100690.

Direct oral anticoagulants and vitamin K antagonists are linked to differential profiles of cardiac function and lipid metabolism.直接口服抗凝剂和维生素 K 拮抗剂与心脏功能和脂代谢的不同特征相关。

Clin Res Cardiol. 2019 Jul;108(7):787-796. doi: 10.1007/s00392-018-1408-y. Epub 2019 Jan 2.

The Effects of Dabigatran and Rivaroxaban on Markers of Polymorphonuclear Leukocyte Activation.达比加群和利伐沙班对多形核白细胞活化标志物的影响。

Pharmaceuticals (Basel). 2018 May 14;11(2):46. doi: 10.3390/ph11020046.

本文引用的文献

Dabigatran etexilate and reduction in serum apolipoprotein B.达比加群酯与血清载脂蛋白B降低

Heart. 2016 Jan;102(1):57-62. doi: 10.1136/heartjnl-2015-307586. Epub 2015 Nov 9.

Differential cellular effects of old and new oral anticoagulants: consequences to the genesis and progression of atherosclerosis.新型与传统口服抗凝剂的细胞效应差异：对动脉粥样硬化发生与进展的影响

Thromb Haemost. 2014 Nov;112(5):909-17. doi: 10.1160/TH14-03-0268. Epub 2014 Oct 9.

Thrombin inhibition by dabigatran attenuates atherosclerosis in ApoE deficient mice.达比加群酯抑制凝血酶可减轻载脂蛋白 E 缺陷小鼠的动脉粥样硬化。

Arch Med Sci. 2014 Feb 24;10(1):154-60. doi: 10.5114/aoms.2014.40742. Epub 2014 Feb 23.

New insights into modulation of thrombin formation.对凝血酶形成的调节作用的新认识。

Curr Atheroscler Rep. 2013 Nov;15(11):363. doi: 10.1007/s11883-013-0363-3.

Genetic and pharmacological modifications of thrombin formation in apolipoprotein e-deficient mice determine atherosclerosis severity and atherothrombosis onset in a neutrophil-dependent manner.载脂蛋白 E 缺陷小鼠凝血酶形成的遗传和药理学修饰以中性粒细胞依赖的方式决定动脉粥样硬化的严重程度和动脉血栓形成的发生。

PLoS One. 2013;8(2):e55784. doi: 10.1371/journal.pone.0055784. Epub 2013 Feb 7.

The beneficial effects of a direct thrombin inhibitor, dabigatran etexilate, on the development and stability of atherosclerotic lesions in apolipoprotein E-deficient mice : dabigatran etexilate and atherosclerosis.直接凝血酶抑制剂达比加群酯对载脂蛋白 E 缺陷小鼠动脉粥样硬化病变的发展和稳定性的有益作用：达比加群酯与动脉粥样硬化。

Cardiovasc Drugs Ther. 2012 Oct;26(5):367-74. doi: 10.1007/s10557-012-6411-3.

The effects of direct thrombin inhibition with dabigatran on plaque formation and endothelial function in apolipoprotein E-deficient mice.达比加群酯对载脂蛋白 E 缺陷小鼠斑块形成和内皮功能的直接凝血酶抑制作用。

J Pharmacol Exp Ther. 2012 Nov;343(2):253-7. doi: 10.1124/jpet.112.194837. Epub 2012 Jul 25.

Dabigatran versus warfarin in patients with atrial fibrillation.达比加群与华法林用于房颤患者的比较。

N Engl J Med. 2009 Sep 17;361(12):1139-51. doi: 10.1056/NEJMoa0905561. Epub 2009 Aug 30.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验